Insidermedicine Daily News (Video)
Insidermedicine is a daily health and medical video news service created by a leading physicians. Our content library contains videos in many languages including English, Chinese, Spanish, on over 100 different diseases. Joining the likes of the Associated Press and Reuters, Insidermedicine's newstories are featured ...
Insidermedicine is a daily health and medical video news service created by a leading physicians. Our content library contains videos in many languages including English, Chinese, Spanish, on over 100 different diseases. Joining the likes of the Associated Press and Reuters, Insidermedicine's newstories are featured by Google News and The News Room. April 25, 2007 Patients with HIV who are treated with protease inhibitors have an increased risk of heart attack, according to a study published in the New England Journal of Medicine. Combination antiretroviral therapy has had a dramatic effect in reducing illness and death associated with the HIV virus, however an earlier study showed that the risk of heart attacks increased by 17% with every year a patient spent on antiretroviral. It isn’t known, though, whether all antiretroviral drugs carry this risk. The assessment of the role of any specific drug is difficult because patients with HIV usually receive a combination of drugs, and often switch regimens because of the availability of newer substances, adverse events, or drug regimen failure. Previous studies have shown a relationship between the use of protease inhibitors, a class of antiretroviral drug, and cardiovascular disease, but there is little information on the risks associated with another class of antiretroviral therapy called nonnucleoside reverse-transcriptase inhibitors. In this study, more than 23,000 patients infected with the HIV virus were assessed to determine the incidence of heart attack and the association between heart attack and exposure to protease inhibitors or nonnucleoside reverse-transcriptase inhibitors. Confirming the earlier results, the researchers found the risk of having a heart attack increased by 16% per year of exposure to protease inhibitors alone, which is equal to twice the risk over five years. Not such effect was observed with nonnucleoside reverse-transcriptase inhibitors. It is thought that protease inhibitors raise the level of blood lipid, thereby increasing the risk of cardiovascular disease and heart attack. Patients treated with protease inhibitors should have their cholesterol and blood pressure levels monitored, and take steps to reduce their lifestyle-related risk factors. This includes maintaining a healthy weight, eating a low-fat diet rich in fruits in vegetables, and getting regular exercise. Reporting for Insidermedicine, I'm Dr. Susan Sharma.
Show all Visit Show Website http://www.insidermedicine.caRecently Aired
-
HD
Metabolic syndrome may raise risk of cardiovascular death
(May 25, 2015 - Insidermedicine) From South Korea - A ...
(May 25, 2015 - Insidermedicine) From South Korea - A new report published in he Journal of Clinical Endocrinology & Metabolism finds that people with metabolic syndrome are raised risk of cardiovascular death. Researchers studied the health records of over 155,000 people participating in a large trial. Participants were followed for a median of 3.7 years. Results showed that those with metabolic syndrome had a 1.6x increased risk of cardiovascular death.
-
HD
Gender of baby may affect woman's risk of diabetes
(May 25, 2015 - Insidermedicine) From Toronto - According to ...
(May 25, 2015 - Insidermedicine) From Toronto - According to research published in the Journal of Clinical Endocrinology & Metabolism, gender of the fetus may affect a woman’s risk of diabetes. Researchers retrospectively reviewed insurance records to examine the diabetes rate among over 643,000 women who had delivered their first child. They found that those who carried a son were more likely to develop gestational diabetes, while those who developed gestational diabetes but carried a daughter were more likely to develop the disease later in life.
-
HD
Cholesterol drug may lower risk of stroke
(May 22, 2015 - Insidermedicine) From France - A new ...
(May 22, 2015 - Insidermedicine) From France - A new report published in the BMJ finds that cholesterol drugs may lower risk of stroke. Researchers followed over 7,400 men and and women with an average age of 74 years. Participants had no history of vascular events and were followed up for an average of nine years. Results showed that those who used a lipid lowering drug (statin or fibrate) had a 30% reduced risk of stroke when compared to nonusers.
-
HD
More than one third of US adults may have metabolic syndrome
(May 22, 2015 - Insidermedicine) From California - Over one ...
(May 22, 2015 - Insidermedicine) From California - Over one third of all US adults are estimated to have metabolic syndrome, according to research published in JAMA. Researchers reviewed data from 2003-2012 taken from the National Health and Nutrition Examination Survey. They found that from 2003-2004 to 2011-2012, overall prevalence of metabolic syndrome increased from 32.9% to 34.7%. They also found that 50% of those over the age of 60 were estimated to have the condition
-
HD
Fitness may delay onset of high cholesterol
(May 21, 2015 - Insidermedicine) From Texas - A new ...
(May 21, 2015 - Insidermedicine) From Texas - A new report published in the Journal of the American College of Cardiology finds that cardiorespiratory fitness may delay high cholesterol. Researchers studied data taken from the Aerobics Centre Longitudinal Study on over 11,000 individuals from 1970 to 2006. An individual’s cardiorespiratory fitness was measured by treadmill test. They found that total cholesterol, LDL cholesterol and triglycerides all increased until mid 40s or early 50s, and then declined, while the opposite held for HDL cholesterol. Those who had higher levels of cardiorespiratory fitness did not see this decline develop until they were in their mid-40s, while those with lower levels saw their bad cholesterol develop in their early 30s.
-
HD
Mediterranean diet associated with improved cognitive function
(May 21, 2015 - Insidermedicine) From Madrid - Eating nuts ...
(May 21, 2015 - Insidermedicine) From Madrid - Eating nuts or olive oil with the Mediterranean diet may improve cognitive functioning in older adults, according to a report published in JAMA Internal Medicine. Researchers studied over 400 healthy volunteers with an average age of 67. Participants had their cognitive change assessed over 4 years, and were randomized to either supplement a Mediterranean diet with one litre of extra virgin olive oil a week, 30 g per day of walnuts, or to a low fat diet as a control. Results showed that individuals on the low fat diet demonstrated significant decrease from baseline in all composites of cognitive function, while individuals in the Mediterranean diet demonstrated improvements in their memory, attention and executive function, and global cognition composites. The authors urge, however, that further study is needed.
-
HD
Weight loss through commuting to work by walking, biking, or public transit
(May 20, 2015 - Insidermedicine) From the UK - Commuting ...
(May 20, 2015 - Insidermedicine) From the UK - Commuting to work by walking, bike or public transport can help people lose weight , according to a report published in the Journal of Epidemiology & Community Health. Researchers examined data on over 4000 participating in the British Household Panel Survey. Those who switched from cars to walking, biking, or public transport saw a average reduction in BMI equivalent to approximately 1 kg over a two year period. Those with longer commutes experienced larger losses, with commutes longer than 30 minutes, resulting in average losses of approximately 7 kg over the period.
-
HD
A healthy lifestyle after bowel cancer improves outcomes
(May 19, 2015 - Insidermedicine) From London - A healthy ...
(May 19, 2015 - Insidermedicine) From London - A healthy lifestyle may decrease mortality after bowel cancer, according to a new report in BMC Medicine. Studying data on over half a million participants researchers constructed a score based on a number of lifestyle factors such as weight, physical activity, diet, and alcohol consumption. A 6 point score for men, and a 7 point score for women. This score was calculated for over half a million participants from 10 countries. A score of 3 or more for men, 4 or more for women was associated with increased survival after bowel cancer.
-
HD
Analysis of frequent users of the ER
(May 19, 2015 - Insidermedicine) From Alberta - People who ...
(May 19, 2015 - Insidermedicine) From Alberta - People who frequently visit emergency care are at raised risk of death, according to a report published in the Emergency Medicine Journal. Researchers conducted a meta-analysis of 31 studies from 1990-2013. Results showed that frequent emergency department users accounted for one in 12 patients seeking emergency care, and around 1 in 4 visits. Researchers also found that frequent users were 2.5x more likely to be admitted to hospital when compared to infrequent users, and over 2x more likely to die than those who rarely visited the emergency department.
-
HD
Epilepsy drug shows promise for Alzheimer's
(May 18, 2015 - Insidermedicine) From British Columbia - A ...
(May 18, 2015 - Insidermedicine) From British Columbia - A new report published in Alzheimer’s Research & Therapy finds that an epilepsy drug may have potential in treating Alzheimer’s disease. Researchers studied a rodent model with Alzheimer’s disease, giving the rodents a low dosage of the epilepsy drug levetiracetam. They found that the drug completely reversed memory loss in the rodents, though it is unclear exactly how the drug works to do so. Larger clinical trials are needed to verify the results.
